Thread by @WildRhino

$TXTM

(1/6)

Protext Pharma is a biotech company engaged in running 2 subsidiaries-- Cannabis Biosciences, Inc & Plandaí Biotechnology South Africa.

They also have a joint partnership with @RSAMMD.

Interested? Continue reading this thread.

$TXTM x Cannabis Biosciences

(2/6)

In 2017, the company acquired Cannabis Biosciences from $PLPL. The company is seeking to:
* Gain a medical cannabis license
* Grow & Cultivate
* Develop & Produce
* Develop South African Cannabis Facility

$TXTM x Plandaí Biotechnology South Africa

(3/6)

Plandaí Biotechnology SA focuses on the development of plant-based medical research & clinical testing.

They have exclusive worldwide license to development of Phytofare®.

$TXTM

(4/6)

Phytofare® is a green-tea derived extract used to protect cells from damage.

In 2017, the company announced their intent to perform human clinical trials and hoped to obtain FDA clearance to market Phytofare®, use to treat Type II diabetes.

$TXTM x RSAMMD

(5/6)

In 2020, $TXTM signed a joint partnership with Republic of South Africa Medical Marijuana Dispensaries. The goals is to:
* Perform testing on $TXTM proprietary cannabis & hemp extraction technology
* Commercialize the extracts
* Have RSAMMD cover all costs

$TXTM

(6/6)

Facts--
* Subsidiaries are active
* Verified OTC Markets profile
* No reverse split

Catalysts--
* Filings coming no later than June 30th
* Update on cannabis facility
* Progress on FDA approval
* Update on all subsidiaries